The following commentary comes from an independent investor or market observer as part of TheStreet's guest contributor program, which is separate from the company's news coverage.
NEW YORK (
(PINK:LRLCY) is going to launch a new range of anti-aging creams in 2012 starting with the European and the U.K. market.
It faces stiff competition from
(EL - Get Report)
in the prestige anti-aging beauty market. Anti-aging today forms the bulk of the facial skin care market, which itself is the largest beauty segment.
Trefis price estimate of $23
implies an upside of about 10% to the current market price.
See full analysis for L'Oreal
Europe and the U.S. together control more than 60% of the global anti-aging cosmetics market share. The market is expected to be dominated by the cosmeceutical segment growing at a CAGR of around 10%, with popular brands like Clinique developed by Estee Lauder and Allergan.
According to Global Industry Analysts, the U.S. market for anti-aging products is expected to grow from around $80 billion in 2011, of which skin care is around $20 billion, to $115 billion by 2015. The fastest growing target segment of the anti-aging market is expected to be 25- to 35- year olds who are progressively more interested in anti-aging products, especially topical skin treatments that are applied directly in the skin.
L'Oreal's anti-aging products in Europe face stiff competition from Estee Lauder, a leading market player in the prestige anti-aging category. Estee Lauder is scheduled to launch
its first global anti-age product
-- Revitalizing Supreme Global Anti-Aging Creme - that is designed specifically for European women, in February 2012.
Global anti-age, a fast-growing segment under anti-aging beauty products, refers to a single, complete product that can treat multiple signs of skin aging at one time.
to find out how a company's products impact its stock price at Trefis.
Like our charts? Embed them in your own posts using the
Trefis Wordpress Plugin